Log in to save to my catalogue

Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease...

Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3f6d430604dc40bba28cfb6d8ef1979d

Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases

About this item

Full title

Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases

Publisher

England: BioMed Central Ltd

Journal title

BMC nephrology, 2019-05, Vol.20 (1), p.193-193, Article 193

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The use of metformin in patients with type 2 diabetes mellitus has been associated with lactic acidosis. However, the information available in patients with moderate-severe chronic kidney disease is scarce.
The ALIMAR-C2 study is a case-control study to assess the association between metformin and lactic acidosis in patients with type 2 diabetes...

Alternative Titles

Full title

Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3f6d430604dc40bba28cfb6d8ef1979d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3f6d430604dc40bba28cfb6d8ef1979d

Other Identifiers

ISSN

1471-2369

E-ISSN

1471-2369

DOI

10.1186/s12882-019-1389-8

How to access this item